Medpace Holdings, Inc. Reports Second Quarter 2025 Results

Revenue of $603.3 million in the second quarter of 2025 increased 14.2% from revenue of $528.1 million for the comparable prior-year period, representing a backlog conversion rate of 21.2%. Net new business awards were $620.5 million in the second quarter of 2025, representing an increase of 12.6%